Evidence map›Paper›PMID 28575375›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2017

Association of C-Reactive Protein With Bacterial and Respiratory Syncytial Virus-Associated Pneumonia Among Children Aged <5 Years in the PERCH Study.

Melissa M Higdon, Tham Le, Katherine L O'Brien, David R Murdoch, Christine Prosperi, Henry C Baggett, W Abdullah Brooks, Daniel R Feikin, Laura L Hammitt, Stephen R C Howie and 28 more

Open access · bronzeAbstract readEvaluation StudyMulticenter Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 106 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 16 institutions in 13 countries.

Melissa M HigdonDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, and.
Tham LeDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, and.
Katherine L O'BrienDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, and.
David R MurdochDepartment of Pathology, University of Otago, and.
Christine ProsperiDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, and.
Henry C BaggettGlobal Disease Detection Center, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi.
W Abdullah BrooksInternational Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka and Matlab.
Daniel R FeikinDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, and.
Laura L HammittDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, and.
Stephen R C HowieMedical Research Council Unit, Basse, The Gambia.
Karen L KotloffDivision of Infectious Disease and Tropical Pediatrics, Department of Pediatrics, Center for Vaccine Development, Institute of Global Health, University of Maryland School of Medicine, Baltimore.
Orin S LevineDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, and.
J Anthony G ScottKenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi.
Donald M TheaCenter for Global Health and Development, Boston University School of Public Health, Massachusetts.
Juliet O AworiKenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi.
Vicky L BaillieMedical Research Council, Respiratory and Meningeal Pathogens Research Unit, and.
Stephanie CascioDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, and.
Somchai ChuananonNakhon Phanom Provincial Hospital, Thailand.
Andrea N DeLucaDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, and.
Amanda J DriscollDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, and.
Bernard E EbrukeMedical Research Council Unit, Basse, The Gambia.
Hubert P EndtzInternational Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka and Matlab.
Anek KaewpanGlobal Disease Detection Center, Thailand Ministry of Public Health-US Centers for Disease Control and Prevention Collaboration, Nonthaburi.
Geoff KahnDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, and.
Angela KaraniKenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi.
Ruth A KarronInternational Health, Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
David P MooreMedical Research Council, Respiratory and Meningeal Pathogens Research Unit, and.
Daniel E ParkDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, and.
Mohammed Ziaur RahmanInternational Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka.
Rasheed SalaudeenMedical Research Council Unit, Basse, The Gambia.
Phil SeidenbergCenter for Global Health and Development, Boston University School of Public Health, Massachusetts.
Somwe Wa SomweDepartment of Paediatrics and Child Health, School of Medicine, University of Zambia, Lusaka.
Mamadou SyllaCentre pour le Développement des Vaccins (CVD-Mali), Bamako; and.
Milagritos D TapiaDivision of Infectious Disease and Tropical Pediatrics, Department of Pediatrics, Center for Vaccine Development, Institute of Global Health, University of Maryland School of Medicine, Baltimore.
Scott L ZegerDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Maria Deloria KnollDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, and.
Shabir A MadhiMedical Research Council, Respiratory and Meningeal Pathogens Research Unit, and.
PERCH Study Group
Johns Hopkins University · USInternational Centre for Diarrhoeal Disease Research · BDRespiratory and Meningeal Pathogens Research Unit · ZACenter for Global Health · USKenya Medical Research Institute · KEMinistry of Public Health · THMRC Unit the Gambia · GMUniversity of Maryland, Baltimore · USBill & Melinda Gates Foundation · USCentre Pour le Développement des Vaccins-Mali · MLGeorge Washington University · USLagos University Teaching Hospital · NGLondon School of Hygiene & Tropical Medicine · GBNakhon Phanom University · THUniversity of Otago · NZUniversity of Zambia · ZM

Funding

Medical Research Council MC_U190088478
6 · The paper itself

Abstract

BACKGROUND.: Lack of a gold standard for identifying bacterial and viral etiologies of pneumonia has limited evaluation of C-reactive protein (CRP) for identifying bacterial pneumonia. We evaluated the sensitivity and specificity of CRP for identifying bacterial vs respiratory syncytial virus (RSV) pneumonia in the Pneumonia Etiology Research for Child Health (PERCH) multicenter case-control study. METHODS.: We measured serum CRP levels in cases with World Health Organization-defined severe or very severe pneumonia and a subset of community controls. We evaluated the sensitivity and specificity of elevated CRP for "confirmed" bacterial pneumonia (positive blood culture or positive lung aspirate or pleural fluid culture or polymerase chain reaction [PCR]) compared to "RSV pneumonia" (nasopharyngeal/oropharyngeal or induced sputum PCR-positive without confirmed/suspected bacterial pneumonia). Receiver operating characteristic (ROC) curves were constructed to assess the performance of elevated CRP in distinguishing these cases. RESULTS.: Among 601 human immunodeficiency virus (HIV)-negative tested controls, 3% had CRP ≥40 mg/L. Among 119 HIV-negative cases with confirmed bacterial pneumonia, 77% had CRP ≥40 mg/L compared with 17% of 556 RSV pneumonia cases. The ROC analysis produced an area under the curve of 0.87, indicating very good discrimination; a cut-point of 37.1 mg/L best discriminated confirmed bacterial pneumonia (sensitivity 77%) from RSV pneumonia (specificity 82%). CRP ≥100 mg/L substantially improved specificity over CRP ≥40 mg/L, though at a loss to sensitivity. CONCLUSIONS.: Elevated CRP was positively associated with confirmed bacterial pneumonia and negatively associated with RSV pneumonia in PERCH. CRP may be useful for distinguishing bacterial from RSV-associated pneumonia, although its role in discriminating against other respiratory viral-associated pneumonia needs further study.

Indexed as

BacteriaBiomarkersCase-Control StudiesChild, PreschoolCommunity-Acquired InfectionsC-Reactive ProteinFemaleHumansInfantInfant, NewbornMaleNasopharynxOropharynxPneumonia, BacterialPneumonia, ViralPolymerase Chain ReactionBiomarkersC-Reactive ProteinbacteriabiomarkerC-reactive proteinpneumonia.RSV

Identifiers

PMID28575375
PMCPMC5447856
OpenAlexW2620538498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.